Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Circulating Biomarkers 2014

Nicholas Dracopoli's Biography



Nicholas Dracopoli, Vice President/Head, Johnson & Johnson

Dr. Nicholas Dracopoli is Vice President, Head Oncology Biomarkers at Janssen R&D, Johnson & Johnson. In this role he is responsible for biomarker discovery, development and applications for oncology products. Previously, he was Vice President of Clinical Discovery Technologies at Bristol-Myers Squibb, and prior to that spent five years in the biotechnology industry at Sequana Therapeutics. Dr Dracopoli obtained his B.Sc. and Ph.D. degrees from the University of London, and completed post-doctoral fellowships at the Memorial Sloan-Kettering Cancer Center and the Massachusetts Institute of Technology (MIT). Subsequently, he served as an Assistant Director at the Whitehead/MIT Genome Center, and as a Section Chief at the National Center for Human Genome Research at the NIH before moving to the biotechnology industry. Dr Dracopoli has authored >70 scientific publications, and has extensive experience in the fields of genomics, molecular biology and cancer research.

Nicholas Dracopoli Image

Big Data and Small Clinical Trials: Translating Biological Data into Predictive Markers

Tuesday, 25 March 2014 at 13:45

Add to Calendar ▼2014-03-25 13:45:002014-03-25 14:45:00Europe/LondonBig Data and Small Clinical Trials: Translating Biological Data into Predictive MarkersCirculating Biomarkers 2014 in Boston, Massachusetts, USABoston, Massachusetts, USASELECTBIOenquiries@selectbiosciences.com

  • Applying biomarkers in oncology drug development
  • PD/MOA markers
  • Predictive and prognostic markers
  • Drug resistance markers
  • Simple biomarkers predicting drug response
  • Complex profiles predicting prognosis


Add to Calendar ▼2014-03-24 00:00:002014-03-25 00:00:00Europe/LondonCirculating Biomarkers 2014Circulating Biomarkers 2014 in Boston, Massachusetts, USABoston, Massachusetts, USASELECTBIOenquiries@selectbiosciences.com